Elanco Animal Health, Inc. (ELAN)
22.14
+0.37
(+1.70%)
USD |
NYSE |
Oct 02, 16:00
21.83
-0.31
(-1.40%)
Pre-Market: 20:00
Elanco Animal Health Enterprise Value : 14.45B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 14.45B |
| October 01, 2026 | 14.26B |
| September 30, 2026 | 14.57B |
| September 29, 2026 | 14.68B |
| September 28, 2026 | 14.60B |
| September 25, 2026 | 14.53B |
| September 24, 2026 | 14.55B |
| September 23, 2026 | 14.66B |
| September 22, 2026 | 14.84B |
| September 21, 2026 | 14.59B |
| September 18, 2026 | 14.59B |
| September 17, 2026 | 14.75B |
| September 16, 2026 | 14.81B |
| September 15, 2026 | 14.88B |
| September 14, 2026 | 14.95B |
| September 11, 2026 | 14.96B |
| September 10, 2026 | 14.81B |
| September 09, 2026 | 15.15B |
| September 08, 2026 | 15.36B |
| September 04, 2026 | 15.63B |
| September 03, 2026 | 15.59B |
| September 02, 2026 | 15.72B |
| September 01, 2026 | 15.33B |
| August 31, 2026 | 15.34B |
| August 28, 2026 | 15.43B |
| Date | Value |
|---|---|
| August 27, 2026 | 15.62B |
| August 26, 2026 | 15.92B |
| August 25, 2026 | 15.92B |
| August 24, 2026 | 15.59B |
| August 21, 2026 | 15.36B |
| August 20, 2026 | 15.16B |
| August 19, 2026 | 15.63B |
| August 18, 2026 | 15.20B |
| August 17, 2026 | 15.18B |
| August 14, 2026 | 15.21B |
| August 13, 2026 | 14.63B |
| August 12, 2026 | 14.44B |
| August 11, 2026 | 14.74B |
| August 10, 2026 | 14.52B |
| August 07, 2026 | 14.44B |
| August 06, 2026 | 15.48B |
| August 05, 2026 | 16.49B |
| August 04, 2026 | 16.18B |
| August 03, 2026 | 16.24B |
| July 31, 2026 | 16.56B |
| July 30, 2026 | 16.61B |
| July 29, 2026 | 16.57B |
| July 28, 2026 | 16.14B |
| July 27, 2026 | 16.08B |
| July 24, 2026 | 15.83B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Zoetis, Inc. | 36.42B |
| Eli Lilly & Co. | 1.122T |
| ANI Pharmaceuticals, Inc. | 1.893B |
| EyePoint, Inc. | 118.09M |
| Amylyx Pharmaceuticals, Inc. | 2.849B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 54.00M |
| Revenue (Quarterly) | 1.368B |
| Total Expenses (Quarterly) | 1.314B |
| EPS Diluted (Quarterly) | 0.1067 |
| Gross Profit Margin (Quarterly) | 48.17% |
| Profit Margin (Quarterly) | 3.95% |
| Earnings Yield | -1.83% |
| Operating Earnings Yield | 3.00% |
| Normalized Earnings Yield | -0.3898 |